Estradiol 2mg tablets

País: Reino Unido

Língua: inglês

Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredientes ativos:

Estradiol

Disponível em:

Abbott Healthcare Products Ltd

Código ATC:

G03CA03

DCI (Denominação Comum Internacional):

Estradiol

Dosagem:

2mg

Forma farmacêutica:

Oral tablet

Via de administração:

Oral

Classe:

No Controlled Drug Status

Tipo de prescrição:

Valid as a prescribable product

Resumo do produto:

BNF: 06040101

Folheto informativo - Bula

- acne
- muscle cramps
- vaginal discharge
- feeling tired
- swelling of the breasts
- change in sex drive
VERY RARE (IN LESS THAN 1 IN 10,000 PATIENTS TREATED, NOT KNOWN
(CANNOT
BE ESTIMATED FROM THE AVAILABLE DATA)):
- reduction in red blood cells which can make the skin pale and cause
weakness or breathlessness (anaemia)
If unscheduled bleeding occurs after some time on HRT, you should
contact
your doctor. If unscheduled bleeding continues after stopping HRT, it
may be
necessary to perform tests to exclude disease of the endometrium
(the lining of the uterus).
Changes can occur in the levels of certain proteins and hormones in
the
blood. The action of the hormones in the body is not affected. You
should tell
your doctor that you are taking HRT if you are to have a blood test.
The following side effects have been reported in association with
estradiol
treatment (frequency unknown):
• fibroids get bigger (growth in the womb increase)
• chorea (muscle twitches)
• worsening of fits (epilepsy)
• blood clots in the arteries (arterial thromboembolism)
• inflammation of the pancreas (pancreatitis) in women with
pre-existing high
levels of certain blood fats (hypertriglyceridemia)
• a condition where gastric juices, containing acid, travel back
from the
stomach into the oesophagus (gastroesophageal reflux disease) symptoms
include heartburn
• liver disorders, which may include jaundice (yellowing of the
skin)
• discolouration of the skin especially of the face or neck known as
‘’pregnancy patches’’ (chloasma)
• rash with target shaped reddening or sores (erythema multiforme)
• skin discolouration (purpura)
• swelling of the skin around face and throat (angioedema)
• urinary incontinence
• painful/lumpy breasts (fibrocystic breast disease)
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor, pharmacist or nurse.
This
includes any possible side effects not listed in this leaflet. You can
also report
side effects directly via the Yellow Card Scheme at: www.mhra.gov.